Fig. 16From: NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysisThese analyses revealed that these dataset’s control and tumor samples could be separated and are ready for the DEG analysis. Blur color represents the control samples and red color represents the tumor samplesBack to article page